Actavis Group ehf. Sustainability Profile
Actavis Group ehf., a prominent player in the global pharmaceutical industry, is headquartered in Iceland (IS). Founded in 1984, the company has established a strong presence in various operational regions, including Europe, North America, and Asia. Actavis is renowned for its extensive portfolio of generic and branded medications, focusing on high-quality, affordable healthcare solutions. With a commitment to innovation, Actavis has achieved significant milestones, including strategic acquisitions that have expanded its market reach. The company’s core products encompass a wide range of therapeutic areas, making them a trusted choice for healthcare providers and patients alike. Actavis Group ehf. is recognised for its robust market position, consistently delivering value through its unique approach to pharmaceutical development and distribution.
DitchCarbon Score
How does Actavis Group ehf.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Actavis Group ehf.'s score of 38 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Actavis Group ehf., headquartered in Iceland (IS), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of AbbVie Inc., which influences its climate commitments and reporting practices. While there are no direct emissions targets or reduction initiatives reported for Actavis Group ehf., it is important to note that any climate commitments or targets may be inherited from its parent company, AbbVie Inc. This includes potential targets set under the Science Based Targets initiative (SBTi) and other climate-related frameworks, which are cascaded down to the subsidiary level. As a part of the broader corporate family, Actavis Group ehf. may align with AbbVie Inc.'s sustainability goals, which could include commitments to reduce greenhouse gas emissions across various scopes, including Scope 1, 2, and 3 emissions. However, specific details regarding these targets or achievements are not available at this time. In summary, while Actavis Group ehf. does not currently provide emissions data or specific reduction targets, it is positioned within a corporate structure that may influence its climate strategy through the practices and commitments of AbbVie Inc.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2005 | 2010 | 2011 | 2012 | 2015 | 2016 | 2017 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 28,218,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 59,189,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is Actavis Group ehf.'s Industry?
How Carbon Intensive is Actavis Group ehf.'s Location?
Actavis Group ehf.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Actavis Group ehf. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
